ReviewInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2025
Looking back to look forward: Has the time arrived for active management of obstetricians in placenta accreta spectrum?
Review in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Towards precision medicine in placenta accreta spectrum: results from a survey-based evaluation of interactive academic international webinars.BMC pregnancy and childbirth · 2026Article
- Diagnosing placenta accreta spectrum.Case reports in women's health · 2026Article
- Strategies for streamlining uterine topographic classification in placenta accreta spectrum.AJOG global reports · 2026Article
- Conservative management of placenta accreta spectrum disorders: a retrospective cohort study.BMC pregnancy and childbirth · 2026Article
- Prenatal ultrasound markers for predicting blood transfusion in placenta accreta spectrum.BMC pregnancy and childbirth · 2026Article
- Patient centered care for placenta accreta spectrum: Exploring implementation of recommendations based on reported patient and healthcare provider experiences.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026Article
- Comparative efficacy of MRI versus ultrasound in prenatal diagnosis of placenta accreta spectrum disorders: a single-tertiary center study.Archives of gynecology and obstetrics · 2025Article
- Evaluation of the topographic classification of placenta accreta spectrum: protocol for an ongoing prospective multicenter study.BMC pregnancy and childbirth · 2025Article
- Placenta accreta spectrum.Nature reviews. Disease primers · 2025Review
- Management and outcomes of women with placenta accreta spectrum grade 3: an INOSS multicountry multiperiod population-based study.BMC pregnancy and childbirth · 2025Article
- Looking back to look forward: Has the time arrived for active management of obstetricians in placenta accreta spectrum?International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025Review
- Comparison of Maternal Outcomes Between Cesarean Hysterectomy and Wedge Resection in Pregnant Women with Figo Grade 2 Placenta Accreta Spectrum.International journal of women's health · 2025Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Placenta accreta spectrum (PAS) is a relatively new obstetric condition which, until recently, was poorly understood. The true incidence is unknown because of the poor quality and heterogeneous diagnostic criteria. Classification systems have attempted to provide clarity on how to grade and diagnose PAS, but these are no longer reflective of our current understanding of PAS. This is particularly true for placenta percreta, which referred to extrauterine disease, as recent studies have demonstrated that placental villi associated with PAS have minimal potential to invade beyond the uterine serosa. It is accepted that PAS is a direct consequence of previous iatrogenic uterine injury, most commonly a previous cesarean section. Here, we "look back to look forwards"-starting with the primary predisposing factor for PAS, an iatrogenic uterine injury and subsequent wound healing. We then consider the evolution of definitions and diagnostic criteria of PAS from its first description over a century ago to current classifications. Finally, we discuss why modifications to the current classifications are needed to allow accurate diagnosis of this rare but life-threatening complication, while avoiding overdiagnosis and potential patient harm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.